uniQure (QURE) shares rallied 247.7% in the last trading session to close at $47.5. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.5% loss over the past four weeks.The massive surge in the stock price was observed after QURE announced that its investigational gene therapy, AMT-130, achieved the primary and key secondary endpoints in a pivotal phase I/II study for Huntington’s disease. The high-dose treatm ...